Epigenetic modification enhances the cytotoxicity of busulfan and4-hydroperoxycyclophosphamide in AML cells
Author:
Funder
National Natural Science Foundation of China
Science and Technology Department of Jiangsu Province
Jiangsu Provincial Medical Talent
National Institutes of Health
Publisher
Elsevier BV
Subject
Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology
Reference46 articles.
1. Busulfan in hematopoietic stem cell transplantation;Ciurea;Biol Blood Marrow Transplant,2009
2. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide;Santos;N Engl J Med,1983
3. Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy);Andersson;Bone Marrow Transplant,2000
4. Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study;Andersson;Biol Blood Marrow Transplant,2002
5. Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation;Bredeson;Blood,2013
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Granulocyte colony-stimulating factor and decitabine-containing conditioning improves survival in myelodysplastic syndrome patients with iron overload undergoing allogeneic hematopoietic stem cell transplantation;2023-08-11
2. The effect of granulocyte-colony stimulating factor, decitabine, and busulfan–cyclophosphamide versus busulfan–cyclophosphamide conditioning on relapse in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia evolving from myelodysplastic syndrome undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised, phase 3 trial;The Lancet Haematology;2023-03
3. Decitabine-primed tandem CD19/CD22 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma patients;Frontiers in Immunology;2022-08-17
4. Allogeneic haematopoietic stem cell transplantation with decitabine-containing preconditioning regimen in TP53-mutant myelodysplastic syndromes: A case study;Frontiers in Oncology;2022-07-18
5. Comparative analysis of Decitabine intensified BUCY2 and BUCY2 conditioning regimen for high-risk MDS patients undergoing allogeneic hematopoietic stem cell transplantation;Bone Marrow Transplantation;2022-04-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3